ATE278408T1 - Arsenic hexaoxide (as406) für die verwendung in krebs-therapie und pharmazeutische zubereitungen - Google Patents

Arsenic hexaoxide (as406) für die verwendung in krebs-therapie und pharmazeutische zubereitungen

Info

Publication number
ATE278408T1
ATE278408T1 AT98401822T AT98401822T ATE278408T1 AT E278408 T1 ATE278408 T1 AT E278408T1 AT 98401822 T AT98401822 T AT 98401822T AT 98401822 T AT98401822 T AT 98401822T AT E278408 T1 ATE278408 T1 AT E278408T1
Authority
AT
Austria
Prior art keywords
cancer therapy
pharmaceutical preparations
sinsuk
as4o6
arsenic
Prior art date
Application number
AT98401822T
Other languages
English (en)
Inventor
Ill-Ju Bae
Jong-Bae Kim
Choong-Ki Eun
Seung-Kyu Song
Byung-Sun Suh
Kwan-Hee Lee
Myoung-Sool Doo
Jin-Hwan Kwak
Byung-Doo Song
Taek-Joon Yoon
Tae-Bong Kang
Choon-Ho B Park
Original Assignee
Ill-Ju Bae
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ill-Ju Bae filed Critical Ill-Ju Bae
Application granted granted Critical
Publication of ATE278408T1 publication Critical patent/ATE278408T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98401822T 1998-05-08 1998-07-17 Arsenic hexaoxide (as406) für die verwendung in krebs-therapie und pharmazeutische zubereitungen ATE278408T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019980016486A KR100272835B1 (ko) 1998-05-08 1998-05-08 천연 화학물질 육산화사비소의 신규한 항종양 치료제로서의 용도 및 그 약학적 조성물
CA002298093A CA2298093C (en) 1998-05-08 2000-02-03 An anti-cancer therapy agent of arsenic hexoxide (as4o6) of a natural chemical substance and its pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE278408T1 true ATE278408T1 (de) 2004-10-15

Family

ID=25681520

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98401822T ATE278408T1 (de) 1998-05-08 1998-07-17 Arsenic hexaoxide (as406) für die verwendung in krebs-therapie und pharmazeutische zubereitungen

Country Status (10)

Country Link
US (2) US6309672B1 (de)
EP (1) EP0955052B1 (de)
JP (1) JP3007627B2 (de)
KR (1) KR100272835B1 (de)
CN (1) CN1163237C (de)
AT (1) ATE278408T1 (de)
CA (1) CA2298093C (de)
DE (1) DE19831579B4 (de)
ES (1) ES2230662T3 (de)
PT (1) PT955052E (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100399657B1 (ko) * 2000-06-29 2003-09-29 배일주 혈관신생 억제제
KR20030002213A (ko) * 2001-06-30 2003-01-08 알앤엘생명과학주식회사 항암 및 암 전이 억제 효과를 갖는 조성물
KR20030075017A (ko) * 2002-03-15 2003-09-22 한국원자력연구소 삼산화비소를 포함하는 혈관신생억제제
US8394422B2 (en) 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
KR100483195B1 (ko) * 2002-08-12 2005-04-14 배일주 육산화사비소를 유효성분으로 함유하는 사상충증예방·치료용 약제학적 조성물
US20050031702A1 (en) * 2003-08-06 2005-02-10 Kayajanian Gary Michael Application of arsenic as a cancer and heart disease prevention agent
US20080214680A1 (en) * 2003-08-06 2008-09-04 Gary Michael Kayajanian Application of arsenic as a cancer prevention agent
CN1546090A (zh) * 2003-12-10 2004-11-17 �Ϻ��ٿ�ҩҵ���޹�˾ 一种抗肿瘤的中药制剂及其制备方法和应用
US7894174B2 (en) * 2004-08-23 2011-02-22 Monolithic Power Systems, Inc. Method and apparatus for fault detection scheme for cold cathode fluorescent lamp (CCFL) integrated circuits
JPWO2006062072A1 (ja) * 2004-12-10 2008-08-07 テムリック株式会社 転移癌治療剤および癌転移抑制剤
CN1319547C (zh) * 2005-06-09 2007-06-06 陈陆敢 治疗前列腺增生的中药制剂
CN101453818B (zh) 2007-11-29 2014-03-19 杭州茂力半导体技术有限公司 放电灯的电路保护和调节装置
KR101572529B1 (ko) 2008-11-14 2015-11-27 배일주 암 치료를 위한 육산화사비소의 병용요법
KR101100786B1 (ko) * 2008-12-16 2011-12-29 (주)천지산 암에 대한 방사선 치료 증진용 조성물
KR101391148B1 (ko) * 2012-03-29 2014-05-07 옥은희 면역 관련 질환 및 산화적 스트레스 관련 질환의 예방 또는 치료용 조성물
CN103816086B (zh) * 2014-03-04 2015-12-30 天津嘉氏堂科技有限公司 一种中药美白组合物及制备方法及应用
CA2988131A1 (en) 2015-06-03 2016-12-08 National Yang-Ming University Therapeutic methods and compositions for treating non-small cell lung cancer
US9890187B2 (en) 2015-06-26 2018-02-13 Epos-Iasis Research And Development, Ltd. Prototype systems of theranostic biomarkers for in vivo molecular management of cancer
CN108066359A (zh) * 2016-11-09 2018-05-25 凯马斯株式会社 包含六氧化四砷的用于抑制癌转移的药物组合物
KR101755556B1 (ko) * 2016-11-18 2017-07-07 주식회사 케마스 육산화사비소의 결정다형을 포함하는 뇌암 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR101834366B1 (ko) 2016-11-21 2018-03-05 주식회사 케마스 육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR101844049B1 (ko) 2016-12-05 2018-03-30 주식회사 케마스 육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물
KR101844050B1 (ko) * 2016-12-09 2018-05-14 주식회사 케마스 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물
KR102240693B1 (ko) 2020-05-18 2021-04-15 주식회사 케마스 육산화사비소를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학조성물
WO2025165158A1 (ko) * 2024-01-29 2025-08-07 배일주 육산화사비소(As4O6)를 포함하는 방광암 예방 또는 치료용 약학 조성물
KR20250118232A (ko) 2024-01-29 2025-08-05 배일주 육산화사비소(As4O6)를 포함하는 방광암 예방 또는 치료용 약학 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539993A1 (fr) * 1983-01-28 1984-08-03 Darcheux Mario Baume agissant sur les plaies cancereuses
US4808221A (en) * 1987-08-25 1989-02-28 Asarco Incorporated Process for the recovery and separation of arsenic from antimony
CN1060935C (zh) * 1992-05-31 2001-01-24 丛繁滋 用于癌病灶直接给药的砷制剂的制备方法
DE4317331A1 (de) * 1993-05-25 1994-12-01 Reischle Karl Georg Behandlung von Schädigungen des Immunsystems
CN1044559C (zh) * 1995-08-23 1999-08-11 哈尔滨医科大学附属第一医院 抗白血病、肝癌、淋巴瘤注射液
TR200002243T2 (tr) * 1997-11-10 2000-12-21 Memorial Sloan-Kettering Cancer Center Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.

Also Published As

Publication number Publication date
DE19831579A1 (de) 1999-11-11
US6589567B2 (en) 2003-07-08
ES2230662T3 (es) 2005-05-01
CA2298093C (en) 2003-03-18
CA2298093A1 (en) 2001-08-03
US20020028253A1 (en) 2002-03-07
PT955052E (pt) 2005-02-28
KR19990084594A (ko) 1999-12-06
DE19831579B4 (de) 2007-03-01
JP3007627B2 (ja) 2000-02-07
US6309672B1 (en) 2001-10-30
EP0955052A1 (de) 1999-11-10
JPH11322616A (ja) 1999-11-24
CN1235124A (zh) 1999-11-17
EP0955052B1 (de) 2004-10-06
KR100272835B1 (ko) 2000-11-15
CN1163237C (zh) 2004-08-25

Similar Documents

Publication Publication Date Title
ATE278408T1 (de) Arsenic hexaoxide (as406) für die verwendung in krebs-therapie und pharmazeutische zubereitungen
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
PL354348A1 (en) Compounds and methods for therapy and diagnosis of lung cancer
SG166775A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
BR9813085A (pt) Processo para o tratamento de tumores sólidos em um mamìfero, de doença neoplásica metastática em um mamìfero, de câncer de melanoma, mama, cólon, ovariano, renal, sistema nervoso central, bexiga, próstata ou pulmão em um humano, de doenças neoplásicas em um humano, de distúrbios hematopoiéticos em um mamìfero, composição farmacêutica oral utilizável para o tratamento de doenças neoplásicas em um humano, e, forma de dosagem unitária estéril
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
WO1999038973A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
GEP20053488B (en) Novel Spiro Compounds
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
EA200700686A1 (ru) Липосомы, включающие радиоактивный изотоп, и цитотоксический агент для комбинированной терапии
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
ATE231849T1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
IL165086A (en) Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
AU2003281193A1 (en) Quinazoline derivatives for use in the treatment of cancer
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
DE50200711D1 (de) Substanzen zur therapie von erkrankungen, die durch hochproliferierende zellen verursacht werden
DE60326931D1 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
BR0000313A (pt) Uso de as4o6, e, composição farmacêutica para o tratamento de câncer
WO1999054466A3 (en) Colon cancer-associated antigens and their diagnostic and therapeutic uses
PT1708693E (pt) Composições farmacêuticas contendo complexos de platina com xantatos secundários e suas utilizações terapêuticas
DE60108622D1 (de) Arzneimittel zur anwendung bei tumorkrankheiten welches ro5-4864 und ein apoptoseauslöser enthält
ATE128354T1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0955052

Country of ref document: EP